Onconetix, Inc. (ONCO) Financial Statements (2026 and earlier)

Company Profile

Business Address 201 E. FIFTH STREET
CINCINNATI, OH 45202
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments5,2216004,55425,753
Cash and cash equivalent5,2216004,55425,753
Receivables3795415036
Inventory, net of allowances, customer advances and progress billings15064364 
Inventory15064364 
Prepaid expense307136610469
Other undisclosed current assets1096160 
Total current assets:6,0679505,83826,258
Noncurrent Assets
Operating lease, right-of-use asset49119149 
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization37636114
Intangible asset, including goodwill, after accumulated amortization18,54927,04981,087 
Goodwill18,54927,04955,676 
Intangible asset, excluding goodwill, after accumulated amortization   25,411 
Prepaid expense   1739
Deferred costs225 366 
Total noncurrent assets:18,86027,23181,68053
TOTAL ASSETS:24,92728,18287,51826,310
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2,1004,6777,4953,908
Accounts payable1,7583,7885,2951,499
Accrued liabilities3428892,2002,409
Debt 9,3289,618 
Derivative instruments and hedges, liabilities6,985 314
Other undisclosed current liabilities514,28674 
Total current liabilities:9,13618,29017,1903,922
Noncurrent Liabilities
Long-term debt and lease obligation   119 
Long-term debt, excluding current maturities   119 
Liabilities, other than long-term debt242813,704 
Deferred income tax liabilities   3,074 
Liability, pension and other postretirement and postemployment benefits  281556 
Operating lease, liability24 74 
Other undisclosed noncurrent liabilities   864 
Total noncurrent liabilities:242814,687 
Total liabilities:9,16018,57121,8773,922
Temporary equity, including noncontrolling interest   64,236 
Equity
Equity, attributable to parent, including:15,7658,543(5,602)22,388
Common stock0000
Treasury stock, value(626)(626)(626)(567)
Additional paid in capital147,836127,82649,42942,331
Accumulated other comprehensive income (loss)(231)(2,723)2,381 
Accumulated deficit(131,215)(115,684)(56,786)(19,377)
Other undisclosed equity, attributable to parent  (250)  
Equity, attributable to noncontrolling interest   7,007 
Total equity:15,7658,5431,40422,388
Other undisclosed liabilities and equity21,068  
TOTAL LIABILITIES AND EQUITY:24,92728,18287,51826,310

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Revenues8152,5245861
Other operating income    61
Cost of revenue(182)(1,469)(1,186)(1)
Cost of product and service sold  (400)(1,152)(1)
Gross profit:6331,055(1,127)61
Operating expenses(18,490)(57,544)(34,907)(13,481)
Other undisclosed operating loss    (61)
Operating loss:(17,857)(56,489)(36,035)(13,481)
Nonoperating income (expense)3,825(3,247)(1,388) 
Other nonoperating income (expense)226169(1,388) 
Interest and debt expense(5,385)(873)(490) 
Loss from continuing operations before equity method investments, income taxes:(19,417)(60,610)(37,912)(13,481)
Other undisclosed income from continuing operations before income taxes5,385873490 
Loss from continuing operations before income taxes:(14,032)(59,736)(37,422)(13,481)
Income tax expense (benefit) (1)1,04513 
Other undisclosed loss from continuing operations    
Net loss:(14,032)(58,691)(37,410)(13,481)
Other undisclosed net income attributable to parent    61
Net loss attributable to parent:(14,032)(58,691)(37,410)(13,420)
Preferred stock dividends and other adjustments (1,499)(206) (96)
Other undisclosed net loss available to common stockholders, basic    
Net loss available to common stockholders, diluted:(15,531)(58,897)(37,410)(13,516)

Comprehensive Income ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Net loss:(14,032)(58,691)(37,410)(13,481)
Other comprehensive income (loss)2,834(5,342)(4) 
Comprehensive loss:(11,198)(64,033)(37,414)(13,481)
Other undisclosed comprehensive income, net of tax, attributable to parent 2382,385 
Comprehensive loss, net of tax, attributable to parent:(11,198)(63,795)(35,029)(13,481)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: